Molecular cardiology is a newly developed technological method in the field of cardiology that aims to administer molecular and biological methods for the diagnosis, prevention, mechanical investigation, and treatment of cardiovascular diseases. Cardiologists focus on molecular mechanisms of signal transduction in cardiomyocytes. The initial criteria is the analysis of pathways regulation affecting heart failure and hypertropic growth .Specifically they investigate modulators of the mitogen activated protein kinase (MAPK) pathway and the Calcineurin pathway applying molecular biology methodology including cell culture, transgenic and knock-out models and protein biochemistry. This innovation has changed theoretical thinking of cardiovascular development, disease etiology and pathophysiology. Although molecular cardiology is still at a very early stage, it has paved assuring pathway for understanding and controlling cardiovascular disease. The description of novel circulating factors that regulate cardiac biology, including aging and hypertrophy is of great interest in the laboratory.
Related Societies: Spanish Heart Foundation | Austrian Heart Foundation | Belorussian Scientific Society of Cardiologists | Asian Pacific Society of Cardiology | Elsevier Society Partners in Cardiology | Cardiac Society of Australia & New Zealand | Russian Society of Cardiology